Pagari Life Science

Biotechnology
$678ktotal raised · 4 rounds on record
$97klatest round · Venture round · Apr 2026 · 6 mo ago
50+team · employees, estimated range
2022founded

Overview

Our Focus:. The Science of Healing. Bringing a new advanced platform of anti-herpetic drugs and advanced healing drugs; that heal faster, eliminate pain, are safe, non-addictive, and effective therapeutics.

Funding and backers

Total raised
$678k
4 rounds on record
Latest round
$97k
Venture round · Apr 2026 · 6 mo ago
Team
51-200
employees, estimated range
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 28 Raised a round Venture round $97k · SEC Form D May 23, 2025 Raised a round Venture round $56k · SEC Form D Mar 26, 2024 Raised a round Venture round $275k · SEC Form D Oct 13, 2023 Raised a round Venture round $250k · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Apr 2026 $97k — SEC Form D
Venture round May 2025 $56k — SEC Form D
Venture round Mar 2024 $275k — SEC Form D
Venture round Oct 2023 $250k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Pagari Life Science Corp. SEC Form D
Founders and leadersfrom filings, registers and the company's site
David FeldkerExecutive Officer, DirectorSEC Form D
Stephen PeipertExecutive Officer, DirectorSEC Form D
Marni ZenkewiczExecutive OfficerSEC Form D
James WickenhauserExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Source Code Capital
backs Starnatx
Portland Seed Fund
backs Thaena
Robin Hood Ventures
backs Gaba Therapeutics
The Idea Village
backs Kubandacryotherapy
Similar startupsby what they do, their industry and backers
Mercury BioVenture round $2.4M · 13 mo ago · 51-200 employees
With a focus on advanced bio-molecular drug delivery systems, Mercury Bio is developing the therapeutic technologies to help more people…
Gaba Therapeutics
Midstage biotech developing GRX-917, a non-addictive anxiety treatment with minimal side effects. Pivotal trials 2027, projected FDA…
AVACEN®Founded 2017
Experience pain relief in the palm of your hand with AVACEN® - designed to improve microcirculation - Safe, Non-Invasive, and FDA Cleared.
SunnyBay BioTechVenture round $2.2M · 3 yr ago · Founded 2022 · 11-50 employees
The challenge. Targeted delivery of anti-cancer drugs directly to tumor cells.
ThaenaFounded 2019
Human postbiotic signals from exceptionally healthy people, delivered as regenerative gut support. Restore what your ecosystem needs to…
Kubandacryotherapy1-10 employees
Kubanda Cryotherapy: Non-invasive, precise tumor treatment for pets. Rapid healing, minimal discomfort. Why wait? Skip the scalpel and heal…

Financials

Total raised
$678k
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $97k Details
Venture - Series Unknown 2025 $56k Details
Venture - Series Unknown 2024 $275k Details
Venture - Series Unknown 2023 $250k Details

People

David Feldker
Executive Officer, Director
SEC Form D
Stephen Peipert
Executive Officer, Director
SEC Form D
Marni Zenkewicz
Executive Officer
SEC Form D
James Wickenhauser
Executive Officer
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

News

Press release pr.com
Pagari Life Science Corp. Announces the Commercial Launch of Helocaine, a New Transformative Cold Sore Treatment
052024 Pagari Life Science Corp. Announces the Commercial Launch of Helocaine, a New Transformative Cold Sore Treatment
Read more
Report